July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
CATARACT SURGERY AND NEOVASCULAR AGE-RELATED MACULAR DEGENERATION DEVELOPMENT OR EXACERBATION: A RETROSPECTIVE ANALYSIS
Author Affiliations & Notes
  • Pietro Monaco
    Ophthalmology, San Martino Hospital, Belluno, Italy
  • Luigina Tollot
    Ophthalmology, San Martino Hospital, Belluno, Italy
  • Michele Del Borrello
    Ophthalmology, San Martino Hospital, Belluno, Italy
  • Antonio Frattolillo
    Ophthalmology, San Martino Hospital, Belluno, Italy
  • Francesco Sperti
    Ophthalmology, San Martino Hospital, Belluno, Italy
  • Daniele Poole
    Ophthalmology, San Martino Hospital, Belluno, Italy
  • Emilio Rapizzi
    Ophthalmology, Dell'Angelo Hospital, Venezia Mestre, Italy
  • Footnotes
    Commercial Relationships   Pietro Monaco, None; Luigina Tollot, None; Michele Del Borrello, None; Antonio Frattolillo, None; Francesco Sperti, None; Daniele Poole, None; Emilio Rapizzi, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 1139. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Pietro Monaco, Luigina Tollot, Michele Del Borrello, Antonio Frattolillo, Francesco Sperti, Daniele Poole, Emilio Rapizzi; CATARACT SURGERY AND NEOVASCULAR AGE-RELATED MACULAR DEGENERATION DEVELOPMENT OR EXACERBATION: A RETROSPECTIVE ANALYSIS. Invest. Ophthalmol. Vis. Sci. 2019;60(9):1139.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To explore whether cataract surgery evokes development or relapse of choroidal neovascularization (CNV) in wet age-related macular degeneration (AMD) patients followed for a 1-year postoperative period.

Methods : 50 eyes of 36 consecutive patients with different wet AMD stages (early-AMD, intermediate-AMD and quiescent-CNV) and visually significant cataract were retrospectively reviewed in our ophthalmology department between 2010 and 2016. Disciform scarring and geographic atrophy were exclusion criteria. The study group (25 eyes) underwent cataract surgery within two weeks. The control group (25 eyes) comprised patients who had cataract surgery deferred until the 12-month visit. Each patient underwent best-corrected visual acuity (BCVA) measurement (expressed in logMAR using ETDRS charts), complete eye examination including digital dynamic fluorescein (FA) and indocyanine green angiography (ICGA) (Heidelberg Engineering) and central foveal thickness (CFT) using optical coherence tomography (OCT) (Spectralis OCT), at baseline and after 1, 3, 6, 9 and 12 months. Antivascular endothelial growth factor (anti-VEGF) injections were performed in case of CNV development or exacerbation detected by fundus exam, FA, ICGA and OCT evaluation. Incidence of neovascular AMD development or exacerbation within 12 months was the primary outcome measure.

Results : The different treatment groups were compared using the Kaplan-Meier (KM) Survival Curves and the Log-Rank Test. The p-value was quite close to significance at the 10% level (p=0.104) probably because of low sample size (low statistical power). The development or exacerbation of choroidal neovascularization was observed in 18 of 25 eyes (72%) in the surgery group versus 9 of 25 eyes (36%) in the deferred surgery group. The study group subjects gained 15.0 letters 1 month after phacoemulsification but lost 15.0 letters at the final 12-months visit vs. 5.0 letters lost for the control group. There was no significant change in foveal thickness in both groups. 2 anti-VEGF injections were performed 10 days before cataract surgery and 48 injections during the follow-up period in the surgery group vs. 23 injections in the deferred group.

Conclusions : In our study, cataract surgery performed in patients with different wet AMD stages could be associated with an increased risk of exacerbation or development of choroidal neovascularization.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×